Schedule II-Condensed Financial Information of Registrant - Statements of Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Condensed Financial Statements, Captions [Line Items]
Net investment income	$ 2,194	$ 2,051	$ 1,825
Total revenues	199,125	177,011	171,340
Interest expense	1,402	1,185	1,030
Total expenses	192,415	169,107	163,625
Loss before income tax benefit and equity in net income of subsidiaries	6,710	7,904	7,715
Shareholders’ net income	5,662	5,980	5,987
Elevance Health, Inc.
Condensed Financial Statements, Captions [Line Items]
Net investment income	45	110	25
Net losses on financial instruments	(101)	(23)	(100)
Service fees	12	9	8
Total revenues	(44)	96	(67)
Operating expense	327	279	352
Interest expense	1,391	1,172	1,017
Total expenses	1,718	1,451	1,369
Loss before income tax benefit and equity in net income of subsidiaries	(1,762)	(1,355)	(1,436)
Income tax benefit	(698)	(477)	(214)
Equity in net income of subsidiaries	6,726	6,858	7,209
Shareholders’ net income	$ 5,662	$ 5,980	$ 5,987